20351334

Source:http://linkedlifedata.com/resource/pubmed/id/20351334

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0205179, umls-concept:C0246415, umls-concept:C0282461, umls-concept:C0332293, umls-concept:C0672663, umls-concept:C0684249
pubmed:issue	13
pubmed:dateCreated	2010-4-30
pubmed:abstractText	To compare vinflunine (VFL) to docetaxel in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) who have experienced treatment failure with first-line platinum-based chemotherapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Platinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/vinflunine
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1527-7755
pubmed:author	pubmed-author:BennounaJaafarJ, pubmed-author:BiesmaBonneB, pubmed-author:DelgadoFrançois MFM, pubmed-author:DouillardJean-YvesJY, pubmed-author:GarridoPilarP, pubmed-author:HansenOlfredO, pubmed-author:JassemJacekJ, pubmed-author:KrzakowskiMaciejM, pubmed-author:QuoixElisabethE, pubmed-author:RamlauRodrygR, pubmed-author:SalhiYacineY, pubmed-author:SantoroArmandoA, pubmed-author:SunXushanX, pubmed-author:SzczesnaAleksandraA, pubmed-author:TanEng-HuatEH, pubmed-author:VaissiereNathalieN, pubmed-author:Von PawelJoachimJ, pubmed-author:ZatloukalPetrP
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2167-73
pubmed:meshHeading	pubmed-meshheading:20351334-Adult, pubmed-meshheading:20351334-Aged, pubmed-meshheading:20351334-Aged, 80 and over, pubmed-meshheading:20351334-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20351334-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:20351334-Chi-Square Distribution, pubmed-meshheading:20351334-Disease-Free Survival, pubmed-meshheading:20351334-Europe, pubmed-meshheading:20351334-Female, pubmed-meshheading:20351334-Humans, pubmed-meshheading:20351334-Lung Neoplasms, pubmed-meshheading:20351334-Male, pubmed-meshheading:20351334-Middle Aged, pubmed-meshheading:20351334-Neoplasm Staging, pubmed-meshheading:20351334-Platinum Compounds, pubmed-meshheading:20351334-Quality of Life, pubmed-meshheading:20351334-Singapore, pubmed-meshheading:20351334-Taxoids, pubmed-meshheading:20351334-Time Factors, pubmed-meshheading:20351334-Treatment Outcome, pubmed-meshheading:20351334-Vinblastine, pubmed-meshheading:20351334-Young Adult
pubmed:year	2010
pubmed:articleTitle	Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.
pubmed:affiliation	Centrum Onkologii Instytut, Warsaw, Poland.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III